• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球现有血液监测系统概述。

Worldwide overview of existing haemovigilance systems.

作者信息

Faber Jean-Claude

机构信息

Blood Transfusion Service, Luxembourg Red Cross, 42-44 Bd, Joseph II L-1840, Luxembourg.

出版信息

Transfus Apher Sci. 2004 Oct;31(2):99-110. doi: 10.1016/j.transci.2004.07.004.

DOI:10.1016/j.transci.2004.07.004
PMID:15501414
Abstract

Haemovigilance is a "quality process" with the aim to improve quality and increase safety of blood transfusion, taking into account that haemovigilance covers and surveys all activities of the blood transfusion chain from donors to recipients. Haemovigilance is indispensable when it comes to safety and quality of blood transfusions. Within the European Union (EU), the European Blood Directive requires haemovigilance in each Member State: the intention has been to rely on the existing or developing national systems. There are significant differences in haemovigilance around the world, in terms of definition, organisational schemes, state of development and implementation. These differences are more pronounced outside the EU: in some countries, even basic traceability causes a problem while in others systems similar as the most developed ones in the EU are implemented.

摘要

血液警戒是一个“质量过程”,旨在提高输血质量和安全性,因为血液警戒涵盖并调查从献血者到受血者的输血链的所有活动。在输血安全和质量方面,血液警戒不可或缺。在欧盟(EU)内部,《欧洲血液指令》要求每个成员国开展血液警戒:其意图是依靠现有的或正在发展的国家系统。在全球范围内,血液警戒在定义、组织架构、发展状态和实施方面存在显著差异。这些差异在欧盟以外更为明显:在一些国家,即使是基本的可追溯性也会引发问题,而在另一些国家,实施的系统与欧盟最发达的系统类似。

相似文献

1
Worldwide overview of existing haemovigilance systems.全球现有血液监测系统概述。
Transfus Apher Sci. 2004 Oct;31(2):99-110. doi: 10.1016/j.transci.2004.07.004.
2
The French Haemovigilance System: organization and results for 2003.法国血液警戒系统:2003年的组织情况与成果
Transfus Apher Sci. 2004 Oct;31(2):145-53. doi: 10.1016/j.transci.2004.07.010.
3
Work of the European Haemovigilance Network (EHN).欧洲血液警戒网络(EHN)的工作。
Transfus Clin Biol. 2004 Feb;11(1):2-10. doi: 10.1016/j.tracli.2003.11.001.
4
[Hemovigilance: a joint responsibility of hospitals and blood banks].[血液监测:医院与血库的共同责任]
Ned Tijdschr Geneeskd. 2003 Aug 2;147(31):1490-2.
5
[What is the use of hemovigilance?].[血液警戒的用途是什么?]
Transfus Clin Biol. 1998 Dec;5(6):415-21.
6
Is haemovigilance improving transfusion practice?--The european experience.血液警戒是否正在改善输血实践?——欧洲的经验。
Dev Biol (Basel). 2007;127:215-24.
7
Quality validation of data in national haemovigilance systems in Europe: report of a survey on current state of practice.欧洲国家血液警戒系统中数据的质量验证:关于当前实践状况的调查报告。
Vox Sang. 2013 Apr;104(3):214-7. doi: 10.1111/j.1423-0410.2012.01659.x. Epub 2012 Oct 13.
8
Transposing the E. E. U. Blood Directive into national law. Perspective of Slovenia.将欧盟血液指令转化为国内法。斯洛文尼亚的视角。
Transfus Clin Biol. 2005 Feb;12(1):21-4. doi: 10.1016/j.tracli.2004.11.004. Epub 2004 Dec 22.
9
Transposition of the Blood Directive into national law--the perspective of Portugal.《血液指令》转化为国内法——葡萄牙的视角
Transfus Clin Biol. 2005 Feb;12(1):18-20. doi: 10.1016/j.tracli.2004.11.003. Epub 2005 Jan 20.
10
6 Years of shot reporting--its influence on UK blood safety.六年的疫苗接种报告——其对英国血液安全的影响。
Transfus Apher Sci. 2004 Oct;31(2):123-31. doi: 10.1016/j.transci.2004.07.006.

引用本文的文献

1
Implementation and performance of haemovigilance systems in 10 sub-saharan African countries is sub-optimal.10 个撒哈拉以南非洲国家的血液监测系统的实施和运行情况并不理想。
BMC Health Serv Res. 2021 Nov 20;21(1):1258. doi: 10.1186/s12913-021-07235-0.
2
Surveillance of Transfusion Related Adverse Reactions in a Tertiary Care Centre in Bangalore: A 4-Year Hemovigilance Initiative.班加罗尔一家三级医疗中心输血相关不良反应的监测:一项为期4年的血液警戒倡议。
Indian J Hematol Blood Transfus. 2020 Oct;36(4):733-739. doi: 10.1007/s12288-020-01312-w. Epub 2020 Jul 1.
3
Analysis of Patterns of Adverse Transfusion Reactions and Management: A Novel Initiative toward Hemovigilance in a Teaching Hospital of South India.
不良输血反应模式分析与管理:印度南部一家教学医院血液警戒的新举措。
J Lab Physicians. 2020 Aug;12(2):133-140. doi: 10.1055/s-0040-1716592. Epub 2020 Sep 2.
4
Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States.美国国家医疗安全网络血液警戒模块对输血相关不良反应的评估。
Transfusion. 2019 Feb;59(2):524-533. doi: 10.1111/trf.15008. Epub 2018 Nov 14.
5
Haemovigilance: A Current Update in Indian Perspective.血液警戒:印度视角的最新进展
J Clin Diagn Res. 2016 Nov;10(11):EE05-EE09. doi: 10.7860/JCDR/2016/21029.8868. Epub 2016 Nov 1.
6
Role of National Accreditation Board of Hospitals and Healthcare Providers (NABH) core indicators monitoring in quality and safety of blood transfusion.医院和医疗服务提供者国家认证委员会(NABH)核心指标监测在输血质量与安全中的作用
Asian J Transfus Sci. 2016 Jan-Jun;10(1):37-41. doi: 10.4103/0973-6247.175394.
7
Transfusion-related adverse reactions: From institutional hemovigilance effort to National Hemovigilance program.输血相关不良反应:从机构血液警戒工作到国家血液警戒计划。
Asian J Transfus Sci. 2016 Jan-Jun;10(1):31-6. doi: 10.4103/0973-6247.175391.
8
Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative.锡金一所教学医院的急性输血反应研究:一项血液警戒举措。
Indian J Pharmacol. 2015 Jul-Aug;47(4):370-4. doi: 10.4103/0253-7613.161257.
9
How is national recipient hemovigilance conducted in the United States?美国是如何开展全国受血者血液警戒工作的?
Transfusion. 2015 Apr;55(4):703-7. doi: 10.1111/trf.12980. Epub 2015 Jan 7.
10
Systems for monitoring transfusion risk.
Blood Transfus. 2008 Apr;6(2):86-92. doi: 10.2450/2008.0039-07.